SLC25A51 and non-small cell lung carcinoma: Upregulation of SLC25A51 enhances mitochondrial NAD+/NADH balance and oxidative phosphorylation, ultimately promoting cell proliferation and migration while inhibiting apoptosis, contributing to NSCLC progression.